Market Closed - Nasdaq Stockholm 11:14:20 2024-04-26 am EDT 5-day change 1st Jan Change
38.7 SEK +0.65% Intraday chart for C-Rad AB -3.49% -8.29%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
C-Rad AB Appoints Mats Thorén as Board Member CI
C-RAD Announces Resignation of Christoffer Herou as CFO, Effective September 25, 2024 CI
C-RAD Receives an Order of SEK 12 Million from Italy, Related to an Extension of the National Consip Tender CI
Transcript : C-Rad AB, Q4 2023 Earnings Call, Feb 08, 2024
C-Rad AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
C-Rad AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
C-Rad AB Wins Order in Croatia of SEK 16 Million CI
C-RAD AB Announces Order from Accuray CI
C-RAD Expands its Presence in South Korea, Soon Supplying Multiple Centers with SGRT Systems CI
Transcript : C-Rad AB, Q3 2023 Earnings Call, Oct 27, 2023
C-Rad AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
C-RAD Signs Partnership Agreement with New Customer in Germany CI
Katholisches Klinikum Bochum Ggmbh ­- St. Josef Hospital in Bochum, Germany Decides to Use the C-RAD SGRT Solution in Its Modernised Radiotherapy CI
C-Rad AB (OM:CRAD B) commences an Equity Buyback Plan, under the authorization approved on May 5, 2023. CI
C-RAD Announces Breast Cancer Treatment Option with Surface Guidance Now Available for Clinical Use in U.S CI
Transcript : C-Rad AB, Q2 2023 Earnings Call, Jul 20, 2023
C-Rad AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
C-Rad AB to Demonstrate Enhancements in Surface Guided Solutions for Advanced Radiotherapy Treatments at AAPM CI
C-Rad AB Expands Its Collaboration with Mvz Prof. Dr. Uhlenbrock Und Partner CI
C-Rad AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Transcript : C-Rad AB, Q1 2023 Earnings Call, May 05, 2023
C-Rad Appoints Christoffer Herou as New CFO CI
C-Rad AB Announces New Order for Catalyst+HD and Sentinel 4DCT CI
Nordstrahl Selects C-Rad AB's Innovative SQRT Solution CI
Transcript : C-Rad AB, 2022 Earnings Call, Jan 26, 2023
Chart C-Rad AB
More charts
C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
38.7 SEK
Average target price
58 SEK
Spread / Average Target
+49.87%
Consensus
  1. Stock Market
  2. Equities
  3. CRAD B Stock
  4. News C-Rad AB
  5. C-RAD Appoints CFO to Start in Q2